VILANTO UF 100+62.5+25MG TAB

VILANTO UF is a triple-combination inhaled medication containing fluticasone furoate, umeclidinium, and vilanterol. Each tablet delivers 100mg fluticasone furoate, 62.5mg umeclidinium, and 25mg vilanterol for comprehensive respiratory support. This combination works synergistically: fluticasone furoate reduces airway inflammation, umeclidinium provides anticholinergic bronchodilation, and vilanterol offers long-acting beta-2 agonist support. Designed for patients with moderate to severe chronic obstructive pulmonary disease (COPD) or asthma requiring multi-modal therapy. VILANTO UF helps improve lung function, reduce exacerbations, and enhance breathing capacity. Suitable for once or twice-daily dosing depending on clinical need. Always use as prescribed by your healthcare provider.